Bauer Jake 4
4 · Enliven Therapeutics, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Bauer Jake
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-13+16,835→ 16,835 totalExercise: $14.85Exp: 2034-02-12→ Common Stock (16,835 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.